Paradoxiom Capital L.P. Invests $4.82 Million in Axon Enterprise, Inc. (NASDAQ:AXON)

Paradoxiom Capital L.P. purchased a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 8,109 shares of the biotechnology company’s stock, valued at approximately $4,819,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. New Wave Wealth Advisors LLC acquired a new position in shares of Axon Enterprise during the 4th quarter worth $40,000. Y.D. More Investments Ltd acquired a new stake in Axon Enterprise in the 4th quarter valued at about $45,000. Stonebridge Financial Group LLC acquired a new stake in Axon Enterprise in the 4th quarter valued at about $53,000. GPS Wealth Strategies Group LLC grew its stake in Axon Enterprise by 74.1% in the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock valued at $56,000 after acquiring an additional 40 shares during the last quarter. Finally, Berbice Capital Management LLC acquired a new stake in Axon Enterprise in the 4th quarter valued at about $59,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Stock Up 4.6%

AXON stock opened at $724.77 on Wednesday. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $732.17. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $56.42 billion, a P/E ratio of 187.28, a PEG ratio of 5.17 and a beta of 1.24. The firm has a 50 day simple moving average of $572.18 and a 200-day simple moving average of $588.52.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping analysts’ consensus estimates of $1.34 by $0.07. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The business had revenue of $603.63 million during the quarter, compared to the consensus estimate of $585.67 million. During the same quarter last year, the company earned $1.15 earnings per share. The business’s quarterly revenue was up 31.3% compared to the same quarter last year. On average, equities research analysts predict that Axon Enterprise, Inc. will post 5.8 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. The Goldman Sachs Group increased their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. Barclays upped their target price on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an “overweight” rating in a report on Friday, May 9th. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. Needham & Company LLC increased their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a “buy” rating in a report on Thursday, May 8th. Finally, Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. One analyst has rated the stock with a sell rating, one has given a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $640.91.

Insiders Place Their Bets

In other Axon Enterprise news, President Joshua Isner sold 9,000 shares of Axon Enterprise stock in a transaction on Monday, May 12th. The shares were sold at an average price of $683.31, for a total value of $6,149,790.00. Following the completion of the transaction, the president now owns 308,714 shares of the company’s stock, valued at $210,947,363.34. The trade was a 2.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Julie A. Cullivan sold 657 shares of Axon Enterprise stock in a transaction on Monday, May 12th. The stock was sold at an average price of $700.00, for a total transaction of $459,900.00. Following the completion of the transaction, the director now directly owns 1,735 shares of the company’s stock, valued at approximately $1,214,500. This represents a 27.47% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 19,964 shares of company stock valued at $12,189,275 over the last 90 days. 4.40% of the stock is owned by company insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.